Secondary prevention of atherothrombotic or cryptogenic stroke

Circulation. 2014 Jan 28;129(4):527-31. doi: 10.1161/CIRCULATIONAHA.112.000658.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anticholesteremic Agents / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Aspirin / therapeutic use
  • Atorvastatin
  • Clopidogrel
  • Drug Therapy, Combination
  • Female
  • Heptanoic Acids / therapeutic use
  • Humans
  • Life Style
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Pyrroles / therapeutic use
  • Recurrence
  • Risk Factors
  • Secondary Prevention / methods*
  • Stroke / epidemiology
  • Stroke / prevention & control*
  • Stroke / therapy*
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use

Substances

  • Anticholesteremic Agents
  • Antihypertensive Agents
  • Heptanoic Acids
  • Platelet Aggregation Inhibitors
  • Pyrroles
  • Atorvastatin
  • Clopidogrel
  • Ticlopidine
  • Aspirin